When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Bullous pemphigoid

Evidence last reviewed: 18 Oct 2026
Topic last updated: 27 Oct 2026

Summary

Definition

History and exam

Key diagnostic factors

  • pruritus
  • tense blisters on normal or erythematous skin
Full details

Other diagnostic factors

  • erythematous or urticarial plaques
  • oral lesions
Full details

Risk factors

  • age 60 to 90 years
  • major histocompatibility complex (MHC) class II allele (DQB1*0301)
  • neurologic conditions
  • use of certain drugs
  • male sex
Full details

Diagnostic tests

1st tests to order

  • skin biopsy for histopathologic evaluation with light microscopy
  • skin biopsy for direct immunofluorescence testing
Full details

Tests to consider

  • ELISA test
  • indirect immunofluorescence test on serum
Full details

Treatment algorithm

ACUTE

localized lesions in children or adults

widespread lesions in adults

widespread lesions in children

Contributors

Authors

Kyle T. Amber, MD, FAAD

Associate Professor of Dermatology

Vice Chair of Research

Director, Dermatology Infusion Center

Rush University

Chicago, IL

Disclosures

KTA has received research support from Argenx, AstraZeneca, Sanofi, Eli Lilly, and KabaFusion. He also consults for Argenx, AstraZeneca, KabaFusion, Caribou, and Akari and has been a speaker for Argenx and KabaFusion.

Acknowledgements

Dr Kyle T. Amber would like to gratefully acknowledge Dr Vesna Petronic-Rosic, the previous contributor to this topic. VPR declares that she has no competing interests.

Peer reviewers

Lawrence Parish, MD

Clinical Professor of Dermatology and Cutaneous Biology

Director

Jefferson Center for International Dermatology

Jefferson Medical College

Thomas Jefferson University

Philadelphia, PA

Disclosures

LP declares that he has no competing interests.

Timothy Patton, MD

Assistant Professor of Dermatology

Department of Dermatology

University of Pittsburgh

Pittsburgh, PA

Disclosures

TP declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Ujiie H, Iwata H, Yamagami J, et al. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). J Dermatol. 2019 Dec;46(12):1102-35.Full text  Abstract

Venning VA, Taghipour K, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol. 2012;167:1200-14.Full text  Abstract

Santi CG, Gripp AC, Roselino AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. An Bras Dermatol. 2019 Apr;94(2 suppl 1):33-47.Full text  Abstract

Singh S, Kirtschig G, Anchan VN, et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2023 Aug 11;8(8):CD002292.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Bullous pemphigoid images
  • Differentials

    • Pemphigus vulgaris
    • Epidermolysis bullosa acquisita
    • Linear IgA dermatosis
    More Differentials
  • Guidelines

    • Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines
    • Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
    More Guidelines
  • Calculators

    Karnofsky Performance Status Score

    More Calculators
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer